Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213 (Q84060246)
Jump to navigation
Jump to search
scientific article published on 01 March 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213 |
scientific article published on 01 March 2011 |
Statements
Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213 (English)
Elizabeth Gore
Kyounghwa Bae
Corey Langer
Martine Extermann
Benjamin Movsas
Paul Okunieff
Gregory Videtic